Related Experiment Video

Updated: Aug 16, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Nuclear receptors as negative modulators of STAT3 in multiple myeloma

Li Hua Wang1, Xiao Yi Yang, Xiaohu Zhang

  • 1Basic Research Program, SAIC-Frederick, National Cancer Institute-Frederick, Frederick, Maryland, USA. lhwang@ncifcrf.gov

Cell Cycle (Georgetown, Tex.)
|January 19, 2005
PubMed

Insights

Novel nuclear receptors, estrogen receptor (ER) and peroxisome proliferator-activated receptor gamma (PPARgamma), can suppress STAT3 signaling. This finding offers new therapeutic strategies for multiple myeloma (MM) by targeting IL-6-driven cancer cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Multiple myeloma (MM) is a hematologic malignancy with limited curative options.
  • Interleukin-6 (IL-6) signaling, mediated by STAT3, is crucial for MM cell survival and proliferation.
  • Nuclear receptors are ligand-activated transcription factors that can modulate cellular signaling pathways.

Purpose of the Study:

  • To investigate the regulatory role of nuclear receptors, specifically estrogen receptor (ER) and peroxisome proliferator-activated receptor gamma (PPARgamma), in STAT3 signaling within MM.
  • To explore the potential therapeutic implications of ER-STAT3 and PPARgamma-STAT3 interactions in MM treatment.

Main Methods:

  • Investigated the regulation of ER and PPARgamma in MM cells.
  • Examined the crosstalk between ER, PPARgamma, and STAT3 signaling pathways.
  • Assessed the impact of nuclear receptor activation on IL-6-mediated MM cell growth and gene expression.

Main Results:

  • Ligand-activated ER and PPARgamma were found to negatively modulate STAT3 activity in MM.
  • Nuclear receptors can suppress STAT3 through direct mechanisms or by recruiting coregulators like PIAS and SMRT.
  • Downregulation of STAT3 function by nuclear receptors led to reduced IL-6-mediated MM cell growth and gene expression.

Conclusions:

  • Nuclear receptors, ER and PPARgamma, represent potential therapeutic targets in multiple myeloma.
  • Targeting the ER-STAT3 or PPARgamma-STAT3 interaction could offer novel treatment strategies for MM by inhibiting IL-6 signaling.
  • These findings highlight the significant therapeutic potential of modulating nuclear receptor-STAT3 crosstalk in MM.

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: